Great news in the world of global health! A recent clinical trial for an experimental malaria vaccine has yielded successful results in protecting a large number of children against malaria with minimal side effects.

ABC News posted a video Thursday entitled “Parasitic Worms,” which features Sabin Vaccine Institute’s Dr. David Diemert discussing Sabin Vaccine Development work in Minas Gerais, Brazil. The video, which was produced in 2010 by Rockhopper, highlights the pervasiveness of hookworm infection among children in Brazil.

In partnership with the Fraunhofer Center for Molecular Biotechnology and the Walter Reid Army Institute for Research, the Sabin Vaccine Institute has successfully expressed the hookworm-derived antigen Na-APR-1.